BB Biotech AG (BION) - Stock Price & Dividends
Exchange: SIX Swiss Exchange • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0038389992
BB Biotech AG, a fund managed by Bellevue Asset Management AG, focuses primarily on investing in companies involved in modern biotechnology for medications and diagnostics. Employing a fundamental analysis approach, the fund explores opportunities in the global public equity markets.
The fund, established on November 9, 1993, operates from Switzerland and has a strong track record in the biotechnology sector. It aims at capitalizing on innovations within the field, offering investors a chance to benefit from the advancements in biotech. More information about BB Biotech AG can be found on their official website: https://www.bbbiotech.ch/en/bb-biotech/
Drawdown (Underwater) Chart
BION Stock Overview
| Market Cap in USD | 2,434m |
| Sector | Healthcare |
| Industry | Biotechnology |
| GiC SubIndustry | Biotechnology |
| TER | 0.00% |
| IPO / Inception |
BION Stock Ratings
| Growth 5y | -1.29 |
| Fundamental | -54.3 |
| Dividend | 5.37 |
| Rel. Performance vs Sector | -1.44 |
| Analysts | - |
| Fair Price Momentum | 44.45 CHF |
| Fair Price DCF | 111.30 CHF |
BION Dividends
| Yield 12m | 4.69% |
| Yield on Cost 5y | 3.86% |
| Dividends CAGR 5y | -1.35% |
| Payout Consistency | 82.6% |
BION Growth Ratios
| Growth 12m | -1.35% |
| Growth Correlation 12m | 20% |
| Growth Correlation 3m | -67% |
| CAGR 5y | -3.84% |
| Sharpe Ratio 12m | -0.29 |
| Alpha vs SP500 12m | -21.33 |
| Beta vs SP500 5y weekly | 0.67 |
| ValueRay RSI | 65.84 |
| Volatility GJR Garch 1y | 21.90% |
| Price / SMA 50 | -2.63% |
| Price / SMA 200 | 4.28% |
| Current Volume | 40k |
| Average Volume 20d | 69.6k |
External Links for BION Stock
What is the price of BION stocks?
As of May 09, 2024, the stock is trading at CHF 42.60 with a total of 40,043 shares traded.
Over the past week, the price has changed by +0.95%, over one month by -1.05%, over three months by -6.93% and over the past year by -4.12%.
As of May 09, 2024, the stock is trading at CHF 42.60 with a total of 40,043 shares traded.
Over the past week, the price has changed by +0.95%, over one month by -1.05%, over three months by -6.93% and over the past year by -4.12%.
What is the forecast for BION stock price target?
According to ValueRays Forecast Model, BION BB Biotech AG will be worth about 48.9 in May 2025. The stock is currently trading at 42.60. This means that the stock has a potential upside of +14.67%.
According to ValueRays Forecast Model, BION BB Biotech AG will be worth about 48.9 in May 2025. The stock is currently trading at 42.60. This means that the stock has a potential upside of +14.67%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 45.2 | 6.01 |
| Analysts Target Price | - | - |
| ValueRay Target Price | 48.9 | 14.7 |